Literature DB >> 2982056

Proteolytic enzymes in tumor metastasis. II. Collagenase type IV activity in subcellular fractions of cloned tumor cell populations.

L Eisenbach, S Segal, M Feldman.   

Abstract

Collagenase type IV degradation activity was examined in metastatic and nonmetastatic clones of the Lewis lung carcinoma (3LL) and of the T10 sarcoma. Conditioned media prepared from cells of both tumors grown in vitro contained low degradation activities, whereas conditioned media from organ cultures of the same clones grown as solid tumors in animals exhibited higher degradation activities. Analysis of subcellular fractions of tumor cells showed that collagenase type IV activity was localized mainly in the cytoplasmic fraction. Crude homogenates or detergent lysates manifested low degradation activities. Little activity was associated with purified plasma membrane preparations and endoplasmic reticular fractions. However, addition of plasma membrane to conditioned media and to cytoplasmic fractions reduced the degradation activities of the cytoplasmic fractions. Possibly a factor that inhibits collagenase type IV exists in the cells in a vesicular form. No correlation between degradation activity and metastatic capacity was demonstrated in the models used in this study. Both metastatic and nonmetastatic clones of the same tumor similarly could degrade basement membrane components.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982056

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  7 in total

Review 1.  A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

2.  Low-molecular-weight membrane component inhibits the metastatic phenotype of B16-F10 melanoma.

Authors:  Z Keren; S J LeGrue
Journal:  Clin Exp Metastasis       Date:  1989 May-Jun       Impact factor: 5.150

Review 3.  Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model.

Authors:  J S Rao; P A Steck; P Tofilon; D Boyd; F Ali-Osman; W G Stetler-Stevenson; L A Liotta; R Sawaya
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

4.  Inhibition of tumor invasion and extracellular matrix degradation by ubenimex (bestatin).

Authors:  J Yoneda; I Saiki; H Fujii; F Abe; Y Kojima; I Azuma
Journal:  Clin Exp Metastasis       Date:  1992-01       Impact factor: 5.150

5.  Establishment of high- and low-invasion clones derived for a human tongue squamous-cell carcinoma cell line SAS.

Authors:  K Okumura; A Konishi; M Tanaka; M Kanazawa; K Kogawa; Y Niitsu
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

6.  Correlation between spontaneous metastatic potential and type I collagenolytic activity in a human pancreatic cancer cell line (SUIT-2) and sublines.

Authors:  S Taniguchi; T Iwamura; T Katsuki
Journal:  Clin Exp Metastasis       Date:  1992-07       Impact factor: 5.150

7.  Inhibition of tumor cell invasion by ubenimex (bestatin) in vitro.

Authors:  I Saiki; J Murata; K Watanabe; H Fujii; F Abe; I Azuma
Journal:  Jpn J Cancer Res       Date:  1989-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.